Cargando...
Terminal arbor degeneration (TAD): a novel lesion produced by the antineoplastic agent, paclitaxel
The anti-neoplastic agent, paclitaxel, causes a dose-limiting distal, symmetrical, sensory peripheral neuropathy that is often accompanied by a neuropathic pain syndrome. In a low-dose model of paclitaxel-evoked painful peripheral neuropathy in the rat, we have shown that the drug causes degeneratio...
Gardado en:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2011
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3086946/ https://ncbi.nlm.nih.gov/pubmed/21395870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1460-9568.2011.07652.x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|